Clinical Study

A Randomized Phase III Trial Evaluating The Role Of Axillary Lymph Node Dissection In Breast Cancer Patients (Ct1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

Posted Date: Jun 29, 2014

  • Investigator: Elizabeth Shaughnessy
  • Co-Investigator: Erica Christensen
  • Specialties: Hematology/Oncology, Oncology, Radiation Oncology, Surgical Oncology, Breast Cancer, Cancer
  • Type of Study: Drug

The purpose of this study is to examine whether removing some of the lymph nodes from the arm pit, but not removing them all followed with radiation therapy (experimental) will be as good as having the majority of the lymph nodes from the arm pit removed during breast surgery followed with radiation (standard of care).


To Qualify You Must Have Breast Cancer That Has Spread To The Lymph Nodes Under Your Arm (In The Arm Pit) And You Have Been Treated With Chemotherapy Before Having Surgery To Remove Any Remaining Breast Cancer.


A011202, Axillary Lymph Node Dissection, Breast Cancer, Ct1-3 N1, Positive Sentinel Lymph Node Disease

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Ride Cincinnati Gives $200,000 in Grants for Breast Cancer Research

    Marlene Harris-Ride Cincinnati has continued its support of UC Cancer Institutescientists with the annual award of five grants to continue promising breastcancer research.